Saltar al contenido principal

Articles

Recent Articles

Precision medicines for neurodegenerative disorders
Articles  —  4 August Aug 2023

Precision medicines for neurodegenerative disorders

Read More about Precision medicines for neurodegenerative disorders
Analytical support for electronic nicotine delivery system (ENDS) and next-generation tobacco and nicotine product (NGP)
Articles  —  7 February Feb 2024

Analytical support for electronic nicotine delivery system (ENDS) and next-generation tobacco and nicotine product (NGP)

Read More about Analytical support for electronic nicotine delivery system (ENDS) and next-generation tobacco and nicotine product (NGP)
Exploring the realities of health equity and diversity in cancer clinical trials
Articles  —  14 November Nov 2022

Exploring the realities of health equity and diversity in cancer clinical trials

Read More about Exploring the realities of health equity and diversity in cancer clinical trials
Expediting a pediatric vaccine trial through site- and participant-centric practices
Articles  —  15 March Mar 2023

Expediting a pediatric vaccine trial through site- and participant-centric practices

Read More about Expediting a pediatric vaccine trial through site- and participant-centric practices
Empowering development and enabling seamless assay transfer
Articles  —  13 December Dec 2023

Empowering development and enabling seamless assay transfer

Read More about Empowering development and enabling seamless assay transfer
The biocompatibility evaluation of liquids, creams, gels and other non-solid medical devices
Articles  —  7 November Nov 2023

The biocompatibility evaluation of liquids, creams, gels and other non-solid medical devices

Read More about The biocompatibility evaluation of liquids, creams, gels and other non-solid medical devices
Potency assays 101: How to develop a CMC relative potency assay
Articles  —  7 December Dec 2023

Potency assays 101: How to develop a CMC relative potency assay

Read More about Potency assays 101: How to develop a CMC relative potency assay
End-to-end support to advance gene therapies for rare retinal diseases
Articles  —  25 October Oct 2023

End-to-end support to advance gene therapies for rare retinal diseases

Read More about End-to-end support to advance gene therapies for rare retinal diseases
Coordinating global capabilities to support a gene therapy targeting a rare neurodegenerative disorder
Articles  —  19 October Oct 2023

Coordinating global capabilities to support a gene therapy targeting a rare neurodegenerative disorder

Read More about Coordinating global capabilities to support a gene therapy targeting a rare neurodegenerative disorder
Environmental Risk Assessment for Pharmaceutical Drugs: Understanding the Evaluation and Implications of Findings to the Regulatory Review of Human Medicines in the Environment
Articles  —  6 April Apr 2023

Environmental Risk Assessment for Pharmaceutical Drugs: Understanding the Evaluation and Implications of Findings to the Regulatory Review of Human Medicines in the Environment

Read More about Environmental Risk Assessment for Pharmaceutical Drugs: Understanding the Evaluation and Implications of Findings to the Regulatory Review of Human Medicines in the Environment
Improving patient experience in Japan with mobile clinical services to support a neuroscience clinical trial
Articles  —  24 January Jan 2023

Improving patient experience in Japan with mobile clinical services to support a neuroscience clinical trial

Read More about Improving patient experience in Japan with mobile clinical services to support a neuroscience clinical trial
Serving as More Than a Partner to Support a Combination Antibiotic Clinical Trial
Articles  —  23 May May 2022

Serving as More Than a Partner to Support a Combination Antibiotic Clinical Trial

Read More about Serving as More Than a Partner to Support a Combination Antibiotic Clinical Trial